Vaibhav Dhyani

Vaibhav Dhyani

Auto-generated profile, based on publicly available information

Vaibhav Dhyani

Thermo-Catalytic Processes Area (TPA), Bio-Fuels Division (BFD), CSIR-Indian Institute of Petroleum (IIP), Dehradun 248005, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Renewable Energy
Verified
Journal Article
Closed access
VDVaibhav Dhyani
Vaibhav Dhyani
BTBhaskar Thallada
Bhaskar Thallada

1 December 2017 in Bioresource Technology
Verified
Journal Article
Closed access
VDVaibhav Dhyani
Vaibhav Dhyani
JKJitendra Kumar
Jitendra Kumar
BTBhaskar Thallada
Bhaskar Thallada

1 March 2018 in Bioresource Technology
Verified
Journal Article
Closed access
VDVaibhav Dhyani
Vaibhav Dhyani
MAMukesh Kumar Awasthi
Mukesh Kumar Awasthi
QWQuan Wang
Quan Wang
JKJitendra Kumar
Jitendra Kumar
XRXiuna Ren
Xiuna Ren
ZZZengqiang Zhang
Zengqiang Zhang

1 February 2019 in Bioresource Technology
Verified
Journal Article
Closed access
AAAyushi Awasthi
Ayushi Awasthi
VDVaibhav Dhyani
Vaibhav Dhyani
BIJOY BISWASBIJOY BISWAS
BIJOY BISWAS
JKJitendra Kumar
Jitendra Kumar
BTBhaskar Thallada
Bhaskar Thallada

22 May 2018 in IOP Conference Series: Earth and Environmental Science
Verified
Conference Paper
Open access
PDF file
BFB. Fekhar
B. Fekhar
NMN. Miskolczi
N. Miskolczi
TBT. Bhaskar
T. Bhaskar
JKJ. Kumar
J. Kumar
VDV. Dhyani
V. Dhyani

1 March 2024 in EMBO Reports
Verified
Journal Article
Open access
CDCallum Dark
Callum Dark
NANashia Ali
Nashia Ali
SGSofya Golenkina
Sofya Golenkina
VDVaibhav Dhyani
Vaibhav Dhyani
RBRonnie Blazev
Ronnie Blazev
LCLouise Y Cheng
Louise Y Cheng
Cancer cachexia is a tumour-induced wasting syndrome, characterised by extreme loss of skeletal muscle. Defective mitochondria can contribute to muscle wasting; however, the underlying mechanisms remain unclear. Using a Drosophila larval model of cancer cachexia, we observed enlarged and dysfunctional muscle mitochondria. Morphological changes were accompanied by upregulation of beta-oxidation proteins and depletion of muscle glycogen and lipid stores. Muscle lipid stores were also decreased in Colon-26 adenocarcinoma mouse muscle samples, and expression of the beta-oxidation gene CPT1A was negatively associated with muscle quality in cachectic patients. Mechanistically, mitochondrial defects result from reduced muscle insulin signalling, downstream of tumour-secreted insulin growth factor binding protein (IGFBP) homologue ImpL2. Strikingly, muscle-specific inhibition of Forkhead box O (FOXO), mitochondrial fusion, or beta-oxidation in tumour-bearing animals preserved muscle integrity. Finally, dietary supplementation with nicotinamide or lipids, improved muscle health in tumour-bearing animals. Overall, our work demonstrates that muscle FOXO, mitochondria dynamics/beta-oxidation and lipid utilisation are key regulators of muscle wasting in cancer cachexia.